MANNATECH INC Stock Issued During Period, Value, Treasury Stock Reissued
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MANNATECH INC stock issued during period, value, treasury stock reissued for the quarter ending 2026-03-31 was $241.00K, a 0.42% increase year-over-year.
- MANNATECH INC stock issued during period, value, treasury stock reissued for the quarter ending 2025-03-31 was $240.00K, a 20.00% increase year-over-year.
- MANNATECH INC stock issued during period, value, treasury stock reissued for the quarter ending 2024-03-31 was $200.00K.
- MANNATECH INC stock issued during period, value, treasury stock reissued for fiscal 2025 was $240.00K, a 20.00% increase from fiscal 2024.
- MANNATECH INC stock issued during period, value, treasury stock reissued for fiscal 2024 was $200.00K.
| Period end | Stock Issued During Period, Value, Treasury Stock Reissued 3 month | Stock Issued During Period, Value, Treasury Stock Reissued 12 month |
|---|---|---|
| 2026-03-31 | $241.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $240.00K 10-K · filed 2026-04-15 | |
| 2025-03-31 | $240.00K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $200.00K 10-K · filed 2026-04-15 | |
| 2024-03-31 | $200.00K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |